Lebrikizumab vs Other Systemic Monotherapies for Moderate to Severe Atopic Dermatitis: Network Meta-analysis of Short-term Efficacy. (2025). SKIN The Journal of Cutaneous Medicine, 9(1), s517. https://doi.org/10.25251/skin.9.supp.517